Forsea A M, Mihai C, Predescu T, Tudose I, Margaritescu I, Giurcaneanu C
"Carol Davila" University of Medicine and Pharmacy, Dept. of Dermatology, Elias University Hospital, Bucharest, Romania.
Dept. of Oncologic Dermatology and Allergology, Bucharest, Romania.
Acta Endocrinol (Buchar). 2017 Jan-Mar;13(1):106-110. doi: 10.4183/aeb.2017.106.
The polyglandular autoimmune syndrome (PAS) type III is a rare condition defined as the coexistence of autoimmune thyroid disorder with other endocrine autoimmune diseases, including type 1 diabetes, without adrenal dysfunction. PAS may associate with other non-endocrine autoimmune diseases, overlapping with the multiple autoimmune syndromes (MAS). We present a case of PAS III/ MAS type 3, including autoimmune thyroiditis, autoimmune diabetes, vitiligo, lupus erythematosus, associated with adult-onset atopic dermatitis, a combination not reported previously.
A 40 years old woman, registered as nurse working in dialysis unit, previously diagnosed with vitiligo, euthyroid autoimmune thyroiditis and disseminated granuloma annulare, with personal and familial history of atopic disorders, presented in our clinic for disseminated eczematous and lichenoid cutaneous rashes. She was tested positive for antinuclear, anti-double stranded DNA and anti-histone antibodies, with inflammatory syndrome and marginal lymphopenia and she was diagnosed with systemic lupus erythematosus (SLE). Subsequently, moderate hyperglycemia, positive anti-glutamic acid decarboxylase antibodies and low C-peptide level prompted the diagnosis of autoimmune diabetes. Recurrent flexural eczematous rashes, with negative epicutaneous tests but positive specific IgE tests for common allergens fulfilled the clinical criteria for the diagnosis of atopic dermatitis. The clinical, immunological and glycemic status were controlled with low doses of oral prednisone (<0.5 mg/kg), methotrexate (10mg/week), antimalarials, metformin, emollients and photoprotection. After changing her workplace, the immunosuppressive treatment could be discontinued, and the patient maintained normal immunological and biochemical profile at 6 months follow-up.This case brings a unique perspective on the evolution, associations spectrum and the management challenges of endocrine polyautoimmunity associated with atopic diathesis.
III型多腺体自身免疫综合征(PAS)是一种罕见疾病,定义为自身免疫性甲状腺疾病与其他内分泌自身免疫性疾病(包括1型糖尿病)共存,且无肾上腺功能障碍。PAS可能与其他非内分泌自身免疫性疾病相关,与多种自身免疫综合征(MAS)重叠。我们报告一例III型PAS/MAS 3型病例,包括自身免疫性甲状腺炎、自身免疫性糖尿病、白癜风、红斑狼疮,并伴有成人期特应性皮炎,这种组合此前未见报道。
一名40岁女性,注册护士,在透析科室工作,此前诊断为白癜风、甲状腺功能正常的自身免疫性甲状腺炎和播散性环状肉芽肿,有特应性疾病的个人和家族史,因播散性湿疹样和苔藓样皮疹前来我院就诊。她抗核抗体、抗双链DNA抗体和抗组蛋白抗体检测呈阳性,伴有炎症综合征和边缘淋巴细胞减少,被诊断为系统性红斑狼疮(SLE)。随后,中度高血糖、抗谷氨酸脱羧酶抗体阳性和C肽水平降低提示自身免疫性糖尿病的诊断。反复出现的屈侧湿疹样皮疹,斑贴试验阴性但对常见变应原的特异性IgE试验阳性,符合特应性皮炎的临床诊断标准。通过低剂量口服泼尼松(<0.5mg/kg)、甲氨蝶呤(10mg/周)、抗疟药、二甲双胍、润肤剂和光防护措施,控制了临床、免疫和血糖状况。更换工作场所后,免疫抑制治疗可以停用,患者在6个月的随访中维持了正常的免疫和生化指标。该病例为与特应性素质相关的内分泌多自身免疫性疾病的演变、关联谱和管理挑战提供了独特视角。